How Much Does Saxenda Cost in 2026?
Saxenda monthly cost by payment channel
| Channel | Monthly cost |
|---|---|
| Insurance + Saxenda Savings Card | $0 to $25 |
| Insurance copay only (no Savings Card) | $25 to $100 |
| Branded telehealth (Hims/Ro/LifeMD) | $399 |
| NovoCare self-pay (Saxenda) | N/A |
| Compounded liraglutide | N/A |
| Cash retail (full WAC) | $1,349 |
The honest comparison: Saxenda vs newer GLP-1s
| Drug | Dosing | Weight loss | List price |
|---|---|---|---|
| Saxenda (liraglutide) | Daily injection | 8.4% (SCALE) | $1,349/mo |
| Wegovy (semaglutide) | Weekly injection | 14.9% (STEP-1) | $1,349/mo |
| Zepbound (tirzepatide) | Weekly injection | 22.5% (SURMOUNT-1) | $1,059/mo |
Same price as Wegovy, dramatically lower efficacy, daily instead of weekly dosing. The only reason to choose Saxenda in 2026 is insurance-driven (your plan grandfathers it on preferred formulary while excluding newer drugs), or patient-specific intolerance to weekly dosing.
Saxenda coverage by major insurer
Coverage stance and per-carrier details for Saxenda. Each link goes to the full prior-auth requirements, cost table, and appeal playbook for that carrier.
Frequently asked questions
How much does Saxenda cost per month in 2026?
Range: $25 to $1,349 per month. With commercial insurance + Saxenda Savings Card: $0 to $25 per fill. Without insurance: $399/month branded telehealth. Cash retail at full list price is $1,349/month - same as Wegovy injection - which almost no one pays. Novo Nordisk does not offer a NovoCare self-pay program for Saxenda the way they do for Wegovy. There is no compounded liraglutide market the way there is for semaglutide and tirzepatide.
Is Saxenda still worth getting in 2026?
Honest answer: usually not, unless your specific insurance plan covers Saxenda but not Wegovy or Zepbound. Saxenda's average weight loss is 8.4% (SCALE trial) versus Wegovy 14.9% (STEP-1) or Zepbound 22.5% (SURMOUNT-1). And Saxenda is a daily injection while Wegovy and Zepbound are once-weekly. At the same list price ($1,349), better newer drugs exist. The only Saxenda use case in 2026: insurance plans that grandfather it on preferred formulary while excluding the newer drugs, or patients who specifically can't tolerate weekly dosing.
How does the Saxenda Savings Card work?
The Saxenda Savings Card from Novo Nordisk drops your commercial-insurance copay to as little as $25 per fill if your plan covers Saxenda. Novo Nordisk covers up to $200 per month of your insurer copay. Government insurance (Medicare, Medicaid, VA, Tricare, DOD) is excluded by federal anti-kickback statute. Apply at saxenda.com/savings.
Why is Saxenda the same list price as Wegovy when it works less well?
Both Saxenda and Wegovy are made by Novo Nordisk and priced at the same WAC ($1,349/month). The pricing is strategic: Novo doesn't want to undercut its own newer, more profitable Wegovy. In practice, manufacturer rebates and discounts mean payers (insurance and PBM contracts) pay much less than list. Saxenda was Novo's flagship until Wegovy launched in 2021; it's now in managed decline as patients and prescribers migrate to weekly dosing.
Should I switch from Saxenda to Wegovy?
Probably yes, if your insurance covers Wegovy. Same active ingredient family (Saxenda is liraglutide, Wegovy is semaglutide - both GLP-1 receptor agonists), but Wegovy produces nearly 2x the weight loss in trials and is dosed once weekly instead of daily. Talk to your prescriber about the switch. Most prescribers will write for Wegovy without resistance once they confirm coverage. If your insurance won't cover Wegovy, NovoCare self-pay at $349/month is still cheaper than Saxenda branded telehealth at $399/month.
Does Medicare cover Saxenda?
Medicare Part D does not cover Saxenda for weight loss alone, same as all GLP-1s for weight-loss-only indications (Medicare Modernization Act of 2003 statutory exclusion). Saxenda is also FDA-indicated for chronic weight management only - it does not have the cardiovascular indication that Wegovy gained in 2024 - so the workaround that lets some Medicare patients access Wegovy does not apply to Saxenda. If you're on Medicare and need a GLP-1, Wegovy with documented ASCVD or Ozempic with T2D are your realistic paths, not Saxenda.
Is there a generic version of Saxenda?
Not yet, as of May 2026. Saxenda's patent on liraglutide expired in 2024 in some jurisdictions, but FDA-approved generic liraglutide for weight management is not yet on the US market. Generic liraglutide for diabetes (under brand Victoza) does exist but is not FDA-approved for weight loss. Compounded liraglutide for weight loss is rare and faces the same FDA enforcement concerns that compounded semaglutide and tirzepatide face. If a generic launches, expect prices to drop significantly - but it would still be a daily injection that is dramatically less effective than once-weekly Wegovy or Zepbound.
Related guides
Stay ahead of every GLP-1 development
We'll email you when something actually matters: new FDA approvals (Foundayo, CagriSema, retatrutide), pricing drops at LillyDirect/NovoCare, telehealth deals, clinical trial results, FDA recalls, and insurance policy changes. ~1-2 emails/month. No filler.